期刊文献+

1616株临床常见病原菌分布及耐药性分析 被引量:7

Distribution and drug resistance of 1616 isolates of common pathogenic bacteria
原文传递
导出
摘要 目的探讨临床常见病原菌分布及耐药性,为临床控制感染选择敏感抗菌药物提供依据。方法用WalkAway 96PLUS自动化微生物鉴定仪进行菌株鉴定,采用微量稀释法和K-B法检测临床分离主要病原菌的耐药率,同时对各种病原菌的分布进行分析。结果 2012年4-6月临床共分离病原菌1616株,分离率前4位病原菌均为革兰阴性杆菌,依次为鲍氏不动杆菌216株占13.3%、肺炎克雷伯菌196株占12.1%、铜绿假单胞菌194株占12.0%、大肠埃希菌177株占11.0%;大肠埃希菌主要从尿液和痰液中检出,检出率分别占45.2%和19.2%;其余病原菌主要从痰液中检出,检出率在73.0%~83.5%;肺炎克雷伯菌和大肠埃希菌对哌拉西林/他唑巴坦、阿米卡星和亚胺培南的耐药率<18.0%,对左氧氟沙星、环丙沙星、阿莫西林/克拉维酸、头孢西丁、头孢唑林和氨苄西林的耐药率在12.4%~100.0%;铜绿假单胞菌和鲍氏不动杆菌对阿米卡星、左氧氟沙星、环丙沙星、头孢吡肟、头孢他啶、庆大霉素、妥布霉素、亚胺培南、头孢噻肟、磺胺甲噁唑/甲氧苄啶、哌拉西林/他唑巴坦耐药率在13.3%~100.0%,且鲍氏不动杆菌的耐药性显著高于铜绿假单胞菌。结论为有效控制病原菌引起的感染,临床上应动态监测常见病原菌的耐药性,根据病原菌的耐药特点合理选用敏感抗菌药物。 OBJECTIVE To investigate the distribution and drug resistance of common clinical isolates of pathogenic bacteria so as to choose sensitive antibiotics for the control of infections. METHODS The strain identification was performed with WalkAway 96 PLUS automatic microbiological instrument, then microdilution method and K-B method were used to test the drug resistance rates of the major species of the isolated pathogens, and the distribution of the pathogens was analyzed. RESULTS A total of 1616 strains of pathogens were isolated from Apr to Jul,2012; the top 4 species of pathogens isolated belonged to the gram-negative bacilli, including 216 (13.3%) strains of Acinetobacter baumannii, 196 (12. 1%) strains of Klebsiella pneumoniae, 194 (12. 0%) strains of Pseudomonas aeruginosa, and 177 (11.0%) strains of Escherichia coli. The E. colt strains were mainly isolated from urine (45.2%) and sputum (19.2%), the rest of the pathogens were mainly isolated from sputum, with the detection rate varying between 73.0% and 83.5%. The drug resistance rates of K. pneumoniae and E. colt to piperacillin-tazobactam, amikacin, and imipenem were less than 18.0 %, the drug resistance rates to levofloxacin, ciprofloxacin, amoxicillin-clavulanic acid, cefoxitin, cefazolin, and ampicillin varied from 12.4% to 100.0%; the drug resistance rates of P. aeruginosa and A. baumannii to amikacin, levofloxaein, ciprofloxacin, eefepime, ceftazidime, gentamicin, tobramycin, imipenem, cefotaxime, sulfamethoxazole-trimethoprim, and piperacillin- tazobactam varied from 13.3 % to 100.0 %, moreover, the drug resistance rate of the A. baumannii was dramatically higher than that of the P. aeruginosa. CONCLUSION It is necessary for the hospital to dynamically monitor the drug resistance of the common pathogens and choose sensitive antibiotics in accordance with the characteristics of drug resistance so as to effectively control the infections.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2013年第21期5293-5295,共3页 Chinese Journal of Nosocomiology
基金 山东省自然科学基金项目(ZR2011HM001)
关键词 病原菌 抗菌药物 耐药性 Pathogen Antibiotic Drug resistance
  • 相关文献

参考文献3

二级参考文献24

  • 1Cisenros JM,Rodringuez Ba noJ. Nosocomial infection due to Acinetobacter baumannii: epidemiology, clinical features and treatment[J].Clin Microbiol Infect, 2002,8(11): 687.
  • 2Mahgou BS,Ahmed J, Glatt AE. Underling characteristics of patients harborin highly resistant Acinenobacter baumannii [J]. Am J InSect Control,2002,30(7) :386-390.
  • 3Rhomberg PR,Jones RN.Summary trends for the Meropenem Yearly Susceptibility Test Information Collection Program:a 10year experience in the United Stales(1999-2008).Diagn Microbiol Infect Dis,2009,65(4):414-426.
  • 4Hawkey PM,Jones AM.The changing epidemiology of resistance.J Antimierob Chemother,2009,64(Suppl1):i3-i10.
  • 5Jacoby GA.AmpC beta-laetamases.Clin Miembiol Bey,2009,22(1):161-182.
  • 6Yigit H,Queenan AM,Anderson GJ,et al.Novel carbapenemhydrolyzing β-lactamase,KPC-1,from a carbapenem-resistant strain of Klebsiella pneumoaiae.Antimicrob Agents Chemother,2001,45(4):1151-1161.
  • 7Nordmnan P,Cuzon G,Naas T.The real threat of Klebsiella pneumoniae earbapenemese-producing bacteria.Lancet Infect Dis,2009,9(4):228-236.
  • 8Strahilevitz J,Jscoby GA,Hooper DC,et al.Plasmid-mediated quinolone resistance:a multifaceted threat.Clin Microbiol Bev,2009,22(4):664-689.
  • 9Collignon P,Gosbell I,Viekery A,et al.Community-acquired meticillin-resistant Staphylococcus aureus in Australia.Australian Group on Antimierobial Resistance.Lancet,1998,352(9122):145-146.
  • 10Tristan A,Bos M,Meugnier H,et al.Global distribution of Panton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus,2006.Emerg Infect Dis,2007,13(4):594-600.

共引文献24

同被引文献47

  • 1裴保香,郭绍来,王睿,周筱青.大肠埃希菌耐药性与头孢菌素类用量变化的相关性分析[J].中华医院感染学杂志,2004,14(4):373-376. 被引量:36
  • 2Sengstock DM, Thyagarajan R, Apalara J,et al. Multidrug resistant Acinetobacter baumannii: an emerging pathogen among older adults in community hospitals and nursing homes[J]. Clini Infect Dis,2010,50: 1611-1616.
  • 3Jung JY,Park MS,Kim SE,et al .Risk factors for multi-drug resistant Acinetobacter baumannii bacteremia in patients with colonization in the intensive care unit[J]. BMC Infect Dis, 2010,10:228.
  • 4Coelho JM ,Turton JF, Kaufman ME, et al .Occurrence of carbapenem- resistant acinetobacter baumanniiclones at multiple hospital in London and Southeast England [J]. J Clinmicrobiol,2006,44: 3623-3627.
  • 5戴显伟,赵浩亮,王新军,等.外科学[M].2版.北京:人民卫生出版社,2011:665-670.
  • 6Koichi Y, Katsunori Y, Nobuko A, et al. Clinical characteristics of tertiary hospital patients from whom Acinetobacter calcoaeeticus -Acinetobacter baumannii complex strains were isolated[J]. In- tern Med,2012,51(1) :51 57.
  • 7Michael Otto. Staphylococcus aureus toxins[J]. Curr Opin Micro- biol,2014,17(1) :32-37.
  • 8Gonzdlez CJ, Cenci C, Rodriguez Adrada E, et al. Staphylococcus aureus infections and factors associated with resistance to methi eillin in a hospital emergency department[J]. Rev Esp Quimioter, 2013,26(3) :337-345.
  • 9Clinical Laboratory Standards Institute. Performance stand-ards for antimicrobial susceptibility testing [ S ]. FifteenthInformation Supplement ,2010.
  • 10胡阳敏,徐翔.我院2002年~2005年抗菌药物的使用与革兰阴性细菌耐药性分析[J].中国抗生素杂志,2008,33(5):307-310. 被引量:12

引证文献7

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部